You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

DOJ Sues to Block Texas Judge’s Ruling Revoking FDA Approval of Abortion Drug

HeadlineApr 11, 2023

The Biden administration has filed a lawsuit seeking to block a Texas federal judge’s ruling that revokes the Food and Drug Administration approval of the abortion pill mifepristone. The Justice Department is asking the U.S. 5th Circuit Court of Appeals to keep the order on hold until a final decision is made. White House Press Secretary Karine Jean-Pierre said Monday the administration is prepared for a long legal fight.

Press Secretary Karine Jean-Pierre: “This decision further strips away Americans’ fundamental freedoms and interferes with a woman’s ability to make decisions about her own body. And it’s another step towards the ultimate goal, that we’ve heard over and over again from anti-choice officials that both the state and — at the both the state and national level, eliminating access to abortion for all women in every state.”

Separately, the Justice Department filed a motion in a federal court in Washington state asking for clarification, after that court issued a conflicting ruling on Friday ordering the FDA to maintain the status quo by keeping mifepristone available. The Washington ruling applies only to 17 states and the District of Columbia with Democratic attorneys general who sued over this issue.

Meanwhile, over 400 pharmaceutical industry executives have signed an open letter condemning the Texas federal judge’s ruling on medication abortions. The letter reads in part, “If courts can overturn drug approvals without regard for science or evidence, or for the complexity required to fully vet the safety and efficacy of new drugs, any medicine is at risk for the same outcome as mifepristone.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top